FLNA earnings date and last-quarter result: last quarter beat, P/E -0.60. Updated 2026-07-23.
Filana Therapeutics (FLNA) Research Hub
Filana Therapeutics (FLNA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.6118 USD (-3.73%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.60, market cap 0.05B. This hub links to the full technical, earnings and options research available for FLNA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.6118 USD (-3.73%) |
| 52-week range | 0.6007 USD – 1.32 USD |
| Trend regime | Range |
| 14-day RSI | 11.4 (Oversold) |
| Trailing P/E | -0.60 |
| Market cap | 0.05B |
| Dividend yield | 0.00% |
Available research for FLNA
Covered Call on FLNA: how it works, illustrative setup around the real 0.6118 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on FLNA: how it works, illustrative setup around the real 0.6118 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on FLNA: how it works, illustrative setup around the real 0.6118 USD price, max profit/loss, breakeven and when to use it. Educational.
FLNA technical analysis: range, last 0.6118 USD, RSI 11.4, 52w range 0.6007 USD–1.32 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is FLNA in?
Filana Therapeutics (FLNA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is FLNA in an uptrend or downtrend?
As of 2026-10-26, FLNA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is FLNA's trailing P/E ratio?
FLNA's trailing P/E is -0.60, with a market cap of 0.05B. See the earnings research page for full valuation detail.